Anhui Huaren Health Pharmaceutical Co. Ltd. Cl A (301408.SZ) stock: key figures, P/E, revenue and dividend

Consumer Staples · Drug Retail · China · ISIN CNE100005YT4

Price
13.93 CNY
Market cap
5.57 bn CNY
P/E (2025)
29.12
P/S (2025)
1.02
Dividend yield
0.72 %
Net margin
3.49 %
Return on equity (ROE)
9.13 %
Return on assets (ROA)
3.49 %

Anhui Huaren Health Pharmaceutical Co. Ltd. Cl A financials

Fiscal year20242025
Revenue4.53 bn CNY5.49 bn CNY
Gross profit1.48 bn CNY1.86 bn CNY
Operating income256.77 m CNY412.96 m CNY
EBIT237.62 m CNY324.61 m CNY
Net income137.70 m CNY191.35 m CNY
Diluted EPS – continuing operations0.34 CNY0.48 CNY

Full history since 2021, charts and your own formulas

This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.

Sign up for freeOpen interactive view

About Anhui Huaren Health Pharmaceutical Co. Ltd. Cl A

Anhui Huaren Health Pharmaceutical Co., Ltd. operates in the medical and healthcare industry. It offers products for oral and throat, nourishing, heat-clearing, respiratory system, and gynecology, as well as provides vitamins and minerals, and detoxifying products. In addition, it provides supplements, and nutrition and health products. Anhui Huaren Health Pharmaceutical Co., Ltd. was founded in 2001 and is based in Hefei, China.

More stocks

All stocks →

Not investment advice. All data without warranty, price as of 30.10.2026. Details in the risk notice.